✦ LIBER ✦

Re-appraisal of risk classifications for primary gastrointestinal stromal tumors (GISTs) after complete resection: indications for adjuvant therapy

✍ Scribed by Yanagimoto, Yoshitomo; Takahashi, Tsuyoshi; Muguruma, Kazuya; Toyokawa, Takahiro; Kusanagi, Hiroshi; Omori, Takeshi; Masuzawa, Toru; Tanaka, Koji; Hirota, Seiichi; Nishida, Toshirou

Book ID: 125352645
Publisher: Springer
Year: 2014
Tongue: English
Weight: 555 KB
Volume: 18
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-014-0386-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant therapy with imatinib mesylate

Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients

✍ Tatsuo Kanda,Toshirou Nishida,Norihito Wada… 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 290 KB

Risk Criteria and Prognostic Factors for

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

✍ Piotr Rutkowski; Zbigniew I. Nowecki; Wanda Michej; Maria Dębiec-Rychter; Agnies 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Adjuvant Imatinib treatment after R0 res

Adjuvant Imatinib treatment after R0 resection for patients with high-risk gastrointestinal stromal tumors: A median follow-up of 44 months

✍ Wei-Zhong Jiang; Guo-Xian Guan; Hui-Shan Lu; Ying-Hong Yang; De-Yong Kang; He-Gu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB